Research Triangle Park
View all Practices by Topic
View All Practices Alphabetically
K&L Gates Hub
Our Approach to the Markets
Our Technological Advantage
Our Ethic of Intergenerational Excellence
Our Commitment to Diversity and Inclusion
Our Engagement in Pro Bono and Public Service
Our Financial Transparency
Global Food, Drugs, Medical Devices and Cosmetics Newsletter
Food, Drugs, Medical Devices and Cosmetics (FDA) Newsletter
M&A Market Trend for Private Company in the U.S.
co-authored, April - July 2014, published by NBL
Japan Enacts Regenerative Medicine Law and Revisions to Pharmaceutical Affairs Law
Food, Drugs, Medical Devices and Cosmetics Alert
18 December 2013
Japan’s New Feed-in Tariffs: Government’s Model Contract Available Now
Energy & Infrastructure Alert
January 18, 2013
Global Government Solutions® 2013: Annual Outlook
K&L Gates Publication
The Government of Japan Officially Defines Power Harassment in the Workplace
Labor and Employment Alert
March 7, 2012
K&L Gates Adds 10-Lawyer Team in Tokyo
K&L Gates has expanded its Tokyo office with the addition of 10 lawyers from Clifford Chance LLP, strengthening K&L Gates’ Asia presence to more than 100 legal professionals across six offices
May 5, 2011
Beyond the Locker Room: Workplace Bullying
12 February 2014
Antitrust, Competition & Trade Regulation
Labor, Employment and Workplace Safety
Resort, Hospitality and Leisure
Telecom, Media and Technology
LL.M., Duke University School of Law, 1996
LL.B., Keio University, 1986
Dai-ni Tokyo Bar Association
Mr. Watanabe is a partner in the firm’s Tokyo office. Mr. Watanabe focuses on cross-border mergers and acquisitions, joint ventures and other corporate alliances in Japan and/or Japanese public and private companies. He advises on a broad range of commercial transactions including distributorships, licensing agreements; employment issues including redundancies, sexual harassment, data protection advice, for Japanese and international manufacturers, retailers, distributors, insurance and other service providers. This includes compliance issues as well as the implementation of various company policies.
Mr. Watanabe has been recognized for his skills and knowledge in the healthcare sector, and has represented a number of healthcare companies. This includes regulatory and compliance advise for Japanese and non-Japanese pharmaceutical companies and medical device manufacturers. Mr. Watanabe serves as an external member of the Internal Clinical Review Board, Indemnification Committee, and Ethical Committee of several healthcare companies.
Keio Law School, Lecturer, teaching Advanced Corporate/Commercial Law (2010 - 2013)
Tokyo Summary-claim Court, Civil Mediator (
minji chotei iin
Dai-ni Tokyo Bar Association, Arbitrator, Arbitration Center
Japan Federation of Bar Association, Vice-Chair of Corporate Compliance Project Team, Practice Committee (2008 - 2013)
Ministry of General Affairs, Arbitrator, Digital Broadcasting Support Center
“Market trend of contractual provisions for international M&A and meeting points for agreement ~ focusing on M&A deals of the U.S. private companies~” FN Communications seminar , September 2014
"EU Data Protection & Data Transfers to Countries outside EU", Japan Pharmaceutical Industry Legal Affairs Association, August 2010
"Practical Tips on Convention of International Sales of Goods", Financial Management Forums, September 2009
"Recent Changes to Pharmaceutical Legislation in Japan", Japanese Pharmaceutical Market Conference (London), February 2009
Represented a Tokyo -based leading telecommunication facilities service provider, in its acquisition of a majority stake in a holding company for various Massachusetts-based companies which provide data center engineering, construction and maintenance services.
Represented a global manufacturer in its strategy on merger filing and examination with JFTC, DOJ and other competition authorities.
Represented global solar power manufacturer and investors in relation to Japanese renewable energy regulations as well as projects.
Represented a TSE-listed company in its acquisition of a CMO biologics business in North Carolina and UK from the US pharmaceutical manufacturer.
Represented a private equity house on its potential acquisition of a super market chain company in Japan.
Advising on an acquisition by Lenovo Group of the personal computer business of IBM Japan.
Advising a private equity house on its acquisition of a global agriculture-chemical company for an enterprise value of US$2.2billion.
Advising a Japanese optical manufacturer on its joint venture with a French optical manufacturer.
Advising a Japanese telecommunication carrier on the sale of its 35% shareholding in Sri Lanka Telecom to a Malaysian telecommunication provider.
Advising a Japanese IT system integrating company on its acquisition of a Japanese subsidiary of a Dutch system integrator.
Advising on a disposal of a Japanese financial information providing business by a Japanese IT system integrator to a US company.
Advising on a joint venture between Nexans and VISCAS on power cable business.
Advising a Japanese imaging company on an acquisition of the medical system business of endoscopes, supersonic waves and pathologies from a Japanese trading company.
Advising a Japanese listed company on a cross-border share-for-share exchange with a UK unlisted company.
Advising international private equity houses in their sale of a Japanese logistics company.
Advising an international private equity house on its potential acquisition of Kanebo Group from the Industrial Reutilisation Company of Japan.
Advising a Japanese consulting service company in its joint venture with a Japanese sewing machine manufacturer.
Advising a global bank of its potential acquisition of a Japanese consumer finance company.
An active member of Clinical Trial Internal Review Board and Indemnification Internal Review Board of Mundipharma KK.
An active member of Internal Ethical Review Board of Nihon L'Oreal KK, R&D Center.
© 2015 K&L Gates LLP. All Rights Reserved. |